白蛋白尿与移植后慢性肾脏病分期可预测移植结局
该回顾性研究利用加拿大阿尔伯塔省关联数据库随访2002-2011年肾移植受者,评估移植后1年估算肾小球滤过率(eGFR)与白蛋白尿分级和随后死亡及移植物丢失的关联。共纳入900例受者,结果示eGFR降低或白蛋白尿加重者全因死亡和死亡删失移植物丢失风险增加。
要点
- 移植后1年eGFR降低或白蛋白尿加重与全因死亡和移植物丢失风险增加相关。
- eGFR 15-29 mL/min/1.73 m2且重度白蛋白尿者全因死亡率117/1000人年,eGFR≥60且正常蛋白排泄者为15/1000人年(率比8)。
- 相应死亡删失移植物丢失率分别为273/1000人年与6/1000人年(率比49)。
核心结论
- 肾移植受者eGFR降低和白蛋白尿加重与死亡及移植物丢失风险增加相关,eGFR与白蛋白尿可联合用于识别、评估和管理不良临床结局高风险受者。
研究设计与样本
- 回顾性研究,利用加拿大阿尔伯塔省关联数据库随访2002-2011年肾移植受者。
- 共900例受者,移植后1年有功能移植物且至少一次门诊血清肌酐和尿蛋白检测。
- 中位年龄51.2岁,女性占38.7%,52%受者eGFR≥60 mL/min/1.73 m2。
主要发现
- eGFR降低或白蛋白尿加重者全因死亡和死亡删失移植物丢失风险增加。
- eGFR 15-29 mL/min/1.73 m2且重度白蛋白尿者全因死亡率为117/1000人年(95%CI 38-371),eGFR≥60 mL/min/1.73 m2且正常蛋白排泄者为15/1000人年(95%CI 9-23),率比8。
- 相应死亡删失移植物丢失率分别为273/1000人年(95%CI 88-1203)与6/1000人年(95%CI 3-9),率比49。
关键数值与推荐
- eGFR分层:≥60、45-59、30-44、15-29 mL/min/1.73 m2。
- 白蛋白尿分层:正常、轻度、重度。
临床怎么用
- 原文结论提出eGFR与白蛋白尿可联合用于识别、评估和管理不良临床结局高风险的移植受者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2012, the KDIGO guidelines updated the classification system for chronic kidney disease to include albuminuria. Whether this classification system predicts adverse clinical outcomes among kidney transplant recipients is unclear. To evaluate this, we conducted a retrospective study using linked databases in Alberta, Canada to follow kidney transplant recipients from 2002-2011. We examined the association between an estimated glomerular filtration rate (eGFR of 60 or more, 45-59, 30-44, 15-29 mL/min/1.73 m2) and albuminuria (normal, mild, heavy) at one year post-transplant and subsequent mortality and graft loss. There were 900 recipients with a functioning graft and at least one outpatient serum creatinine and urine protein measurement at one year post-transplant. The median age was 51.2 years, 38.7% were female, and 52% had an eGFR of 60 mL/min/1.73 m2 or more. The risk of all-cause mortality and death-censored graft loss was increased in recipients with reduced eGFR or heavier albuminuria. The adjusted incidence rate per 1000 person-years of all-cause mortality for recipients with an eGFR of 15-29 mL/min/1.73 m2 and heavy albuminuria vs. an eGFR 60 mL/min/1.73 m2 or more and normal protein excretion was 117 (95% confidence interval 38-371) vs. 15 (9-23) (rate ratio 8). Corresponding rates for death-censored graft loss were 273 (88-1203) vs. 6 (3-9) (rate ratio 49). Reduced eGFR and heavier albuminuria in kidney transplant recipients are associated with an increased risk of mortality and graft loss. Thus, eGFR and albuminuria may be used together to identify, evaluate, and manage transplant recipients who are at higher risk of adverse clinical outcomes.
引用
- Lam NN, Tonelli M, Lentine KL, et al. Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes. Kidney Int. 2017. PMID: 28366228. doi:10.1016/j.kint.2017.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。